INTELGENX TECHNOLOGIES CORP.
INTELGENX TECHNOLOGIES CORP. (IGXT): 7 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.2 months
D/E -1.43 · 0% dilution
Lead: Approved
7 candidates
N/A
N/A
A transparent, data-derived signal for INTELGENX TECHNOLOGIES CORP.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$772K
Quarterly Burn
$2.9M
Runway
1.2 mo
Revenue
$174K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (7 candidates)
| Drug | Phase |
|---|---|
| cannabis infused versafilm | Approved |
| loxapine oral film | Preclinical |
| montelukast versafilm | Phase 2 |
| rizaport | Approved |
| salvinorin a film | Preclinical |
| tadalafil oral film | Phase 2 |
| vls-01 | Preclinical |
Frequently asked questions
How many drug candidates are in INTELGENX TECHNOLOGIES CORP.'s pipeline?
INTELGENX TECHNOLOGIES CORP. (IGXT) has 7 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is INTELGENX TECHNOLOGIES CORP.'s lead drug candidate?
INTELGENX TECHNOLOGIES CORP.'s most advanced tracked candidate is cannabis infused versafilm (Approved) for adult-used medical cannabis.
What is INTELGENX TECHNOLOGIES CORP.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, INTELGENX TECHNOLOGIES CORP. has approximately 1.2 months of cash runway.
Who is the CEO of INTELGENX TECHNOLOGIES CORP.?
Dwight Gorham Dwight is the chief executive officer of INTELGENX TECHNOLOGIES CORP. (IGXT).
Get the full picture on INTELGENX TECHNOLOGIES CORP.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.